Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Neha SL"'
Publikováno v:
Letters in Drug Design & Discovery. 20
Background: Silymarin is a flavonoid utilised in liver dysfunction for years; new studies have emphasised its potential utility as a therapy for nanoparticulate targeting in many other disorders. In order to establish the product quality of such comp
Publikováno v:
Current drug targets. 23(15)
Background: The pathogenesis of hepatic diseases involves several cells which makes the delivery of pharmaceutical agents complicated. Many severe liver diseases affecting the worldwide population cannot be effectively treated. Major hindrance or cha
Autor:
Neha SL; Head of Department of Pharmaceutics, Delhi Institute of Pharmaceutical Science And Research, Delhi Pharmaceutical Science And Research University, New Delhi, India., Mishra AK; Head of Department of Pharmaceutics, Delhi Institute of Pharmaceutical Science And Research, Delhi Pharmaceutical Science And Research University, New Delhi, India., Rani L; Head of Department of Pharmaceutics, Delhi Institute of Pharmaceutical Science And Research, Delhi Pharmaceutical Science And Research University, New Delhi, India., Paroha S; Head of Department of Pharmaceutics, Delhi Institute of Pharmaceutical Science And Research, Delhi Pharmaceutical Science And Research University, New Delhi, India., Dewangan HK; University Institute of Pharma Sciences (UIPS), Chandigarh University NH-05, Chandigarh Ludhiana Highway, Mohali, India., Sahoo PK; Head of Department of Pharmaceutics, Delhi Institute of Pharmaceutical Science And Research, Delhi Pharmaceutical Science And Research University, New Delhi, India.
Publikováno v:
Journal of microencapsulation [J Microencapsul] 2023 Dec; Vol. 40 (8), pp. 599-612. Date of Electronic Publication: 2023 Nov 09.